Overview

Trial Evaluating Folic Acid Supplementation by Concomitant Administration of Ethinyl Estradiol + Levonorgestrel

Status:
Completed
Trial end date:
2013-09-17
Target enrollment:
Participant gender:
Summary
This trial evaluated folic acid supplementation after oral administration of the ethinyl estradiol + levonorgestrel + folic acid (0.02 mg + 0.10 mg + 0.4 mg) coated tablet (Level-Fol® Biolab Sanus Farmacêutica, São Paulo, Brazil) in healthy female volunteers, based on statistical comparisons of folate levels in erythrocytes. Its safety and tolerability was also evaluated.
Phase:
Phase 3
Details
Lead Sponsor:
Galeno Desenvolvimento de Pesquisas Clínicas
Collaborator:
Biolab Sanus Farmaceutica
Treatments:
Estradiol
Estradiol 17 beta-cypionate
Estradiol 3-benzoate
Estradiol valerate
Ethinyl Estradiol
Ethinyl estradiol, levonorgestrel drug combination
Folic Acid
Levonorgestrel
Polyestradiol phosphate
Vitamin B Complex